NVS : NYSE
Industry: Pharmaceuticals

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash2,0155,3603,8186,299
Short Term Investments4,0337,8424,1434,596
ASSETS
Cash & Short Term Investments6,04713,2027,96110,894
Receivables - Net8,4758,5057,9786,540
Raw Materials968940811663
Finished Goods4,7584,5153,6913,049
Inventories - Total5,7265,4554,5023,712
Prepaid Expenses394270244221
Other Current Assets007370
CURRENT ASSETS - TOTAL20,64327,43221,42121,367
Land651630570418
Buildings8,4637,9887,1606,046
Machinery & Equipment12,17511,66710,4439,084
Property, Plant and Equipment - Gross23,70022,80119,71916,456
Accumulated Depreciation(10,749)(10,168)(8,765)(7,807)
Property, Plant and Equipment - Net12,95112,63410,9548,648
Investments in Associated Companies17,5106,9456,1167,061
Other Investments1,1691,3192,3151,903
Deferred Charges1802,3092,1041,912
Total Intangible Other Assets - Net20,58221,25021,24713,247
Other Assets - Total25,13527,12727,25718,548
TOTAL ASSETS73,03571,89064,15754,139
LIABILITIES
Accounts Payable3,3563,0182,4891,954
Short Term Debt & Current Portion of Long Term Debt5,1275,1176,6487,110
Accrued Payroll1,5911,140879648
Income Taxes Payable1,3601,7191,1621,249
Other Current Liabilities4,8825,6475,0694,314
CURRENT LIABILITIES - TOTAL16,31616,64216,24715,274
Capitalized Lease Obligations581219
Long Term Debt2,1536776571,314
Provision for Risks and Charges4,4593,8074,1934,433
Deferred Taxes - Credit4,0974,4665,2943,460
Deferred Taxes - Debit4,3733,5673,9063,389
DEFERRED TAXES(276)8991,38871
Other Liabilities5204653440
TOTAL LIABILITIES23,17222,49022,83021,092
EQUITY
Non-Equity Reserves0000
Minority Interest147173183173
Preferred Stock0000
Common Stock948990991990
Capital Surplus196198198198
Other Appropriated Reserves(2,792)(722)(1,347)(2,084)
Retained Earnings49,25845,03439,76433,809
Unrealized Foreign Exchange Gain/Loss2,1033,4941,288(217)
Unrealized Gain/Loss on Marketable Securities140407390322
Treasury Stock(137)(175)(140)(145)
COMMON EQUITY49,71649,22641,14532,873
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY73,03571,89064,15754,139
SHARE INFORMATION
Common Shares Outstanding2,265------
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/31/08
2008 Q3
9/30/08
Cash------2,015--
ASSETS
Cash & Short Term Investments14,16611,7497,8046,0477,936
Receivables - Net9,9669,1758,8398,4758,975
Inventories - Total6,3086,0965,7385,7265,811
Prepaid Expenses------394--
Other Current Assets00000
CURRENT ASSETS - TOTAL30,44027,02022,38020,64322,722
Property, Plant and Equipment - Gross------23,700--
Accumulated Depreciation------(10,749)--
Property, Plant and Equipment - Net13,87013,37012,45912,95112,668
Investments in Associated Companies------17,510--
Total Intangible Other Assets - Net22,35220,52419,88720,58220,743
Other Assets - Total46,37643,41242,77826,30344,605
TOTAL ASSETS90,68683,80177,61873,03579,996
LIABILITIES
Accounts Payable3,2763,3013,2473,3562,830
Short Term Debt & Current Portion of Long Term Debt5,6604,6474,4545,1278,525
Income Taxes Payable------1,360--
Other Current Liabilities8,9667,3247,2216,4728,106
CURRENT LIABILITIES - TOTAL17,90215,27214,92216,31619,462
Capitalized Lease Obligations------5--
Long Term Debt8,7069,1446,9462,1532,012
Deferred Taxes - Credit------4,097--
Deferred Taxes - Debit------4,373--
DEFERRED TAXES------(276)--
Other Liabilities10,7659,1809,7304,9799,037
TOTAL LIABILITIES37,37333,59731,59923,17230,511
EQUITY
Non-Equity Reserves00000
Minority Interest00000
Preferred Stock00000
Common Stock------948--
Capital Surplus------196--
Retained Earnings------49,258--
Unrealized Foreign Exchange Gain/Loss------2,103--
Unrealized Gain/Loss on Marketable Securities------140--
Treasury Stock------(137)--
COMMON EQUITY53,31350,20546,01949,71649,485
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY90,68683,80277,61873,03579,996
SHARE INFORMATION
Common Shares Outstanding2,2712,2652,2632,2652,265
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted